Voxcan in collaboration with Bonac Corporation, a Japanese bio-venture company, has recently set-up a preclinical model in a K18-hACE2 transgenic mouse (from The Jackson Laboratory, USA) infected with a French SARS-CoV-2 viral strain by intra-nasal (i.n.) instillation. This year Voxcan has the great honor to give a talk at I4ID event to present you our sars-cov-2 infected K18-hACE2 mice model as well as a panel of obtained readouts including virus detection over the first 5 days post infection, which was evaluated by qPCR in oropharyngeal swabs, and lungs at the early stages of infection at D02 and later at D05. Assessment of tissue structure and inflammation state have been also evaluated by histology (HES staining). Voxcan invites you to join us at I4ID event to learn more about our internal capabilities for sars-Cove-2 infected models.
